ABCL — ABCELLERA BIOLOGICS INC
As of Q2 2026, 20 SEC-registered investment managers reported holding ABCL (ABCELLERA BIOLOGICS INC) in their latest 13F filings, with a combined reported value of $360.70M across 47.53M shares. That is -1.5% by share count (-709.55K shares) versus the previous quarter, while reported value moved +114.2%. Ownership is concentrated: the five largest holders account for 79.9% of reported value and the top ten for 96.6%.
Compared with the prior quarter, 4 opened new positions, 7 added to existing stakes, 9 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ABCL is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Capital World Investors history | Q2 2026 | 13.59M | $106.67M | 0.01% | Add |
| Two Sigma Investments history | Q2 2026 | 10.44M | $81.93M | 0.06% | Reduce |
| Baillie Gifford & Co history | Q3 2025 | 10.42M | $52.43M | 0.04% | Add |
| Bank of America Corp history | Q2 2026 | 6.14M | $48.21M | 0.00% | Add |
| Harvard Management Company history | Q1 2023 | 4.11M | $30.95M | 3.30% | Hold |
| BlackRock Inc history | Q2 2026 | 3.81M | $29.87M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 2.75M | $21.58M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 2.07M | $16.25M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 1.90M | $14.93M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 1.67M | $13.10M | 0.00% | Reduce |
| Casdin Capital history | Q1 2024 | 2.36M | $10.69M | 0.80% | Hold |
| Arrowstreet Capital history | Q2 2026 | 1.04M | $8.16M | 0.00% | New |
| Renaissance Technologies history | Q2 2026 | 990.93K | $7.78M | 0.01% | Reduce |
| BNY Mellon history | Q1 2023 | 787.98K | $5.94M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 518.57K | $4.07M | 0.00% | Reduce |
| Point72 Asset Management history | Q1 2026 | 1.15M | $4.01M | 0.01% | Add |
| Charles Schwab Investment Management history | Q1 2023 | 472.39K | $3.56M | 0.00% | Add |
| Temasek Holdings history | Q2 2022 | 281.73K | $3.00M | 0.02% | New |
| Geode Capital Management history | Q2 2026 | 315.72K | $2.48M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 298.62K | $2.34M | 0.00% | Add |
New Positions (Q2 2026)
- Arrowstreet Capital 1.04M sh · $8.16M
- D. E. Shaw & Co 45.43K sh · $356.63K
- JPMorgan Chase & Co 21.85K sh · $177.43K
- T. Rowe Price Associates 1.59M sh · $12.46K
Fully Exited (vs previous quarter)
- Point72 Asset Management sold 1.15M sh · $4.01M
- Lazard Asset Management sold 305.22K sh · $1.07M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital World Investors | 19.82M | 22.05M | 18.27M | 13.04M | 9.58M | 9.33M | 9.33M | 8.42M | 8.42M | 8.35M | 8.35M | 5.32M | — | 7.93M | 13.36M | 13.36M | 13.36M | 13.36M | 13.36M | 13.59M |
| Two Sigma Investments | 84.10K | 515.60K | 495.98K | 727.92K | 1.20M | 960.71K | 762.35K | 1.06M | 1.20M | 1.07M | 1.48M | 2.06M | 2.53M | 3.26M | 3.13M | 4.11M | 5.18M | 5.81M | 10.56M | 10.44M |
| Bank of America Corp | 2.45K | 4.11K | 11.64K | 44.38K | 76.36K | 97.43K | 165.36K | 42.76K | 176.53K | 171.52K | 157.08K | 10.24K | 19.08K | 17.14K | 15.97K | 224.37K | 2.42M | 2.63M | 3.00M | 6.14M |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 3.99M | 4.10M | 3.58M | 3.68M | 3.64M | 3.87M | 4.04M | 3.81M |
| Citadel Advisors | 721.32K | 765.09K | 457.54K | 825.50K | 1.12M | 2.02M | 1.86M | 2.56M | 1.18M | 1.02M | 874.23K | 1.57M | 1.67M | 892.25K | 2.01M | 3.17M | 1.48M | 2.23M | 1.88M | 2.75M |
| UBS Group AG | 63.41K | 79.19K | 62.42K | 41.35K | 343.94K | 74.25K | 66.90K | 13.37K | — | 2.50K | 101.97K | 94.99K | 21.75K | 1.98M | 5.08M | 3.45M | 2.49M | 1.94M | 4.21M | 2.07M |
| Marshall Wace | 338.12K | — | — | 513.71K | 354.40K | 97.60K | — | — | — | — | — | — | — | — | 47.48K | 47.48K | 47.48K | — | 359.68K | 1.90M |
| Morgan Stanley | 736.02K | 500.97K | 393.14K | 479.00K | 703.01K | 635.53K | 909.40K | 1.18M | 581.41K | 376.89K | 390.14K | 552.13K | 589.65K | 937.38K | 1.29M | 996.93K | 2.79M | 3.00M | 2.22M | 1.67M |
| Arrowstreet Capital | — | — | — | — | 327.62K | — | — | — | — | — | — | — | — | — | — | — | 736.95K | 209.93K | — | 1.04M |
| Renaissance Technologies | 84.30K | 539.20K | 2.62M | 4.04M | 2.98M | 2.12M | 2.81M | 2.54M | 1.69M | 1.46M | 1.49M | 1.73M | 2.95M | 2.49M | 2.89M | 3.31M | 3.36M | 2.39M | 1.51M | 990.93K |
| Millennium Management | 847.82K | 696.36K | 1.49M | 3.25M | 1.17M | 588.45K | 1.51M | 3.27M | 1.77M | 1.26M | 1.27M | 450.69K | 753.89K | 1.48M | 869.71K | 3.40M | 2.43M | 1.77M | 1.29M | 518.57K |
| Geode Capital Management | 31.66K | 201.87K | 202.71K | 1.93M | 1.99M | 2.07M | 2.18M | 251.67K | 255.30K | 256.14K | 257.37K | 314.87K | 113.65K | 113.77K | 350.89K | 363.19K | 329.22K | 313.47K | 309.39K | 315.72K |
| Northern Trust Corp | — | — | — | 1.42M | 1.51M | 1.74M | 1.69M | 100.27K | — | 56.48K | 47.69K | 40.38K | 39.45K | 81.62K | 75.07K | 75.78K | 218.03K | 208.07K | 204.62K | 298.62K |
| Goldman Sachs Group | 18.75K | 135.45K | 112.72K | 234.49K | 401.22K | 464.88K | 351.35K | 420.28K | 259.30K | 601.24K | 206.43K | 95.77K | 205.71K | 299.81K | 86.48K | 218.72K | 250.22K | 4.34M | 3.75M | 235.13K |
| Wells Fargo & Co | 146.39K | 92.18K | 63.05K | 73.09K | 76.89K | 84.33K | 143.14K | 111.98K | 36.84K | 30.32K | 28.12K | 15.68K | 12.88K | 13.13K | 13.13K | 11.80K | 13.00K | 14.90K | 15.90K | 60.34K |
| Invesco Ltd | 28.11K | — | — | 77.36K | 82.05K | 78.19K | 95.21K | — | — | — | 11.43K | 13.74K | 10.95K | 11.25K | 24.15K | 37.11K | 42.69K | 54.60K | 60.40K | 49.75K |
| D. E. Shaw & Co | 250.29K | 290.71K | 29.10K | 1.10M | 2.78M | 2.45M | 1.47M | 512.80K | 435.35K | 30.63K | 453.24K | 466.56K | 420.24K | — | — | 51.07K | 76.48K | 77.78K | — | 45.43K |
| JPMorgan Chase & Co | — | 82.04K | 150.88K | 410.10K | 500.13K | 593.18K | 450.35K | 474.73K | 536.29K | 409.26K | 370.76K | 334.26K | 355.75K | 281.03K | 204.25K | 135.44K | 130.66K | 77.61K | — | 21.85K |
| Citigroup Inc | 572.18K | 383.25K | 11.02K | 32.72K | 10.08K | 7.67K | 5.14K | 8.02K | 4.26K | 8.10K | 4.04K | 79.29K | 5.23K | 12.62K | 4.34K | 14.46K | 5.75K | 8.35K | 8.47K | 7.18K |
| T. Rowe Price Associates | — | — | — | 19.76K | 33.71K | 35.96K | 39.92K | — | — | — | — | — | — | — | — | — | — | — | — | 1.59M |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details